Named on 2 rounds in the feed, most often at Series D+.
Rounds from 2024-03-06 to 2026-01-07
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Rakuten Medical Rakuten Medical develops cancer therapies based on the Alluminox® platform, aimed at treating various cancers. | Series F Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $100M | 2026-01-07 | [ PART ] |
Rakuten Medical Rakuten Medical develops cancer therapies based on the Alluminox® platform, aimed at treating various cancers. | Series E Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $119M | 2024-03-06 | [ PART ] |
No sector on record.